Niktimvo (axatilimab-csfr)

Niktimvo (axatilimab-csfr) is a colony-stimulating factor-1 receptor (CSF-1R)–blocking antibody used for the treatment of chronic graft-versus-host disease (cGVHD) after the failure of at least two prior lines of systemic therapy in adult and pediatric patients weighing at least 40 kg.

Recommended Dosage: The recommended dosage of Axatilimab-csfr for adults and pediatric patients weighing 40 kg and above is 0.3 mg/kg, with a maximum dose of 35 mg, administered every 2 weeks. Axatilimab-csfr injection is given as an intravenous infusion for over 30 minutes. Ensure proper dosage for effective treatment while minimizing risks. Consult your healthcare provider (HCP) for accurate dosage and guidelines.

• Axatilimab-csfr 50 mg/mL injection may cause serious infusion-related reactions, including fever, chills, and shortness of breath. It’s crucial to monitor patients closely during administration. If reactions occur, stop the infusion immediately and provide appropriate treatment. Consult your healthcare provider for safety measures when using the medicine.
• Before starting this therapy, it is crucial to monitor AST, ALT, ALP, CPK, amylase, and lipase levels. These tests should be performed every 2 weeks during the first month and subsequently every 1 to 2 months. Monitoring ensures that any abnormalities are detected and resolved promptly, ensuring safe treatment.
• Use of Axatilimab-csfr 50 mg/mL injection during pregnancy may harm the fetus. Patients of childbearing potential should be advised to use effective contraception during treatment and for some time afterward. Discuss with your healthcare provider the risks of medication to ensure safe use during pregnancy.
• It is unknown whether this therapeutic drug is excreted in human milk. Due to the potential for serious adverse reactions in nursing infants, women should avoid breastfeeding during treatment with Axatilimab-csfr and for a recommended period afterward. Consult a healthcare professional for personalized advice.

What documents are required to import NIKTIMVO to India?

NIKTIMVO (axatilimab-csfr) injection can be imported by patients or government hospitals on the name of the patients only. 

The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order be confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable

Is NIKTIMVO available in India?

NIKTIMVO (axatilimab-csfr injections) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• On availability of Niktimvo in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
• Medicine Price.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

NIKTIMVO can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of NIKTIMVO (prescription medicines) to all locations in the world and India after fulfilling the legal requirement (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Niktimvo 50 mg/mL injection price in India. 

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

What is the Generic Name for the trade name drug Niktimvo®?

What is the Manufacturer’s Name of Niktimvo®?

Is Niktimvo® approved by the FDA?

What is the dosage and form of Niktimvo® supplied?

What are the most common side effects of Niktimvo®? 

How much does Niktimvo® 50 mg/mL injection cost in India?

Can Niktimvo® 50 mg/mL injections be available in SAARC countries? 

Is it safe to buy Niktimvo® 50 mg/mL injections online in India?

What are the storage conditions of Niktimvo® 50 mg/mL injections?